Policy Address Preview: Hong Kong's R&D Spending Lags Behind Shenzhen District — Can Hard Targets Enable Recovery?
HK01 · 1 SOURCESabout 2 hours ago2 MIN
Summary
Hong Kong's innovation and technology sector faces a stark challenge: the city's entire R&D expenditure falls short of what Shenzhen's Nanshan District alone invests. According to government statistics, Hong Kong's R&D spending as a percentage of GDP was merely 1.1% in 2024, equivalent to approximately HK$35 billion . In contrast, Nanshan District—a area of just 185 square kilometres—contributed 7.66% of its GDP to R&D, totalling approximately RMB72.78 billion (HK$85.1 billion) . Sources suggest the SAR government will announce more ambitious mandatory targets in the upcoming Policy Address, moving beyond the current reference indicators outlined in the 2022 Hong Kong Innovation and Technology Development Blueprint.
Key Points
- Hong Kong's R&D expenditure reached approximately HK$35 billion in 2024, accounting for just 1.1% of GDP, with 57% funded by government
- Shenzhen's Nanshan District contributed 7.66% of its GDP to R&D in 2024, totalling approximately HK$85.1 billion with 90% from enterprises
- The 2022 Blueprint set targets of 1.3% by 2025 and 2% by 2030, but these remain non-binding reference indicators
- Hong Kong's manufacturing sector has declined from 25% of GDP during peak years to less than 1% today after four decades of industrial hollowing
- Legislative Council member Jonathan Wu Jiezhuang recommends hard targets include government procurement of local R&D products to help startups
- Government has invested over HK$100 billion in Northern Metropolis development, including the Hong Kong-Shenzhen Innovation and Technology Park
Why It Matters
The gap between Hong Kong's R&D investment and that of a single Shenzhen district underscores decades of industrial decline and the urgency for decisive action . With hard targets potentially coming in the Policy Address, Hong Kong must leverage its strengths—such as world-class universities and a rich pool of medical professionals—to cultivate homegrown technology giants, particularly in biotechnology, rather than attempting to compete directly in sectors where other regions have already gained significant advantages .
The gap between Hong Kong's R&D investment and that of a single Shenzhen district underscores decades of industrial decline and the urgency for decisive action . With hard targets potentially coming in the Policy Address, Hong Kong must leverage its strengths—such as world-class universities and a rich pool of medical professionals—to cultivate homegrown technology giants, particularly in biotechnology, rather than attempting to compete directly in sectors where other regions have already gained significant advantages .